NIAID Banner Logo Image

HIV Citation List: November 23 - December 6, 2012

PubMed citations

1. Characterization of Peripheral and Mucosal Immune Responses in Rhesus macaques on Long-term Tenofovir and Emtricitabine Combination Antiretroviral Therapy. Jasny, E., S. Geer, I. Frank, P. Vagenas, M. Aravantinou, A.M. Salazar, J.D. Lifson, M. Piatak, Jr., A. Gettie, J.L. Blanchard, and M. Robbiani. Journal of Acquired Immune Deficiency Syndromes (1999), 2012. 61(4): p. 425-435. PMID[22820802].

[PubMed]. HIV_1123-120612.

2. Design of a Novel Cyclotide-based CXCR4 Antagonist with anti-Human Immunodeficiency Virus (HIV)-1 Activity. Aboye, T.L., H. Ha, S. Majumder, F. Christ, Z. Debyser, A. Shekhtman, N. Neamati, and J.A. Camarero. Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[23151033].

[PubMed]. HIV_1123-120612.

3. Discovery of Novel 2-(3-(2-Chlorophenyl)pyrazin-2-ylthio)-N-arylacetamides as Potent HIV-1 Inhibitors Using a Structure-based Bioisosterism Approach. Zhan, P., W. Chen, Z. Li, X. Li, X. Chen, Y. Tian, C. Pannecouque, E.D. Clercq, and X. Liu. Bioorganic & Medicinal Chemistry, 2012. 20(23): p. 6795-6802. PMID[23098609].

[PubMed]. HIV_1123-120612.

4. Inhibitory Effect of HIV-Specific Neutralizing IgA on Mucosal Transmission of HIV in Humanized Mice. Hur, E.M., S.N. Patel, S. Shimizu, D.S. Rao, P.N. Gnanapragasam, D.S. An, L. Yang, and D. Baltimore. Blood, 2012. 120(23): p. 4571-4582. PMID[23065154].

[PubMed]. HIV_1123-120612.

5. Microwave-assisted Combinatorial Synthesis of 2-Alkyl- 2-(N-arylsulfonylindol-3-yl)-3-N-acyl-5-aryl-1,3,4-oxadiazolines as anti-HIV-1 Agents. Che, Z.P., N. Huang, X. Yu, L.M. Yang, J.Q. Ran, X. Zhi, H. Xu, and Y.T. Zheng. Combinatorial Chemistry & High Throughput Screening, 2012.

[Epub ahead of print];PMID[23176059].

[PubMed]. HIV_1123-120612.

6. Most Rhesus macaques Infected with the CCR5-Tropic SHIVAD8 Generate Cross-reactive Antibodies That Neutralize Multiple HIV-1 Strains. Shingai, M., O.K. Donau, S.D. Schmidt, R. Gautam, R.J. Plishka, A. Buckler-White, R. Sadjadpour, W.R. Lee, C.C. Labranche, D.C. Montefiori, J.R. Mascola, Y. Nishimura, and M.A. Martin. Proceedings of the National Academy of Sciences of the United States of America, 2012. 109(48): p. 19769-19774. PMID[23129652].

[PubMed]. HIV_1123-120612.

7. New Furanones from the Plant Endophytic Fungus Pestalotiopsis besseyi. Liu, H., S. Liu, L. Guo, Y. Zhang, L. Cui, and G. Ding. Molecules, 2012. 17(12): p. 14015-14021. PMID[23187285].

[PubMed]. HIV_1123-120612.

8. POMA Analyses as New Efficient Bioinformatics' Platform to Predict and Optimise Bioactivity of Synthesized 3a,4-Dihydro-3h-indeno[1,2-C]pyrazole-2-carboxamide/Carbothioamide Analogues. Ahsan, M.J., J. Govindasamy, H. Khalilullah, G. Mohan, J.P. Stables, C. Pannecouque, and E.D. Clercq. Bioorganic & Medicinal Chemistry Letters, 2012. 22(23): p. 7029-7035. PMID[23099090].

[PubMed]. HIV_1123-120612.

9. Rational Design of Potent Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase. Chong, P., P. Sebahar, M. Youngman, D. Garrido, H. Zhang, E.L. Stewart, R.T. Nolte, L. Wang, R.G. Ferris, M. Edelstein, K. Weaver, A. Mathis, and A. Peat. Journal of Medicinal Chemistry, 2012.

[Epub ahead of print];PMID[23137340].

[PubMed]. HIV_1123-120612.

10. Small-molecule APOBEC3G DNA Cytosine Deaminase Inhibitors Based on a 4-Amino-1,2,4-triazole-3-thiol Scaffold. Olson, M.E., M. Li, R.S. Harris, and D.A. Harki. ChemMedChem, 2012.

[Epub ahead of print];PMID[23180603].

[PubMed]. HIV_1123-120612.

11. Structural Modifications of 5,6-dihydroxypyrimidines with anti-HIV Activity. Guo, D.L., X.J. Zhang, R.R. Wang, Y. Zhou, Z. Li, J.Y. Xu, K.X. Chen, Y.T. Zheng, and H. Liu. Bioorganic & Medicinal Chemistry Letters, 2012. 22(23): p. 7114-7118. PMID[23099098].

[PubMed]. HIV_1123-120612.

12. Structure-based Bioisosterism Design, Synthesis and Biological Evaluation of Novel 1,2,4-Triazin-6-ylthioacetamides as Potent HIV-1 NNTRIs. Zhan, P., X. Li, Z. Li, X. Chen, Y. Tian, W. Chen, X. Liu, C. Pannecouque, and E.D. Clercq. Bioorganic & Medicinal Chemistry Letters, 2012. 22(23): p. 7155-7162. PMID[23084898].

[PubMed]. HIV_1123-120612.

13. Synthesis and anti-HIV Properties of New Carbamate Prodrugs of AZT. Solyev, P.N., A.V. Shipitsin, I.L. Karpenko, D.N. Nosik, L.B. Kalnina, S.N. Kochetkov, M.K. Kukhanova, and M.V. Jasko. Chemical Biology & Drug Design, 2012. 80(6): p. 947-952. PMID[22958368].

[PubMed]. HIV_1123-120612.

14. Synthesis and Evaluation of Novel 4-Substituted styryl quinazolines as Potential Antimicrobial Agents. Modh, R.P., A.C. Patel, D.H. Mahajan, C. Pannecouque, E. De Clercq, and K.H. Chikhalia. Archiv der Pharmazie, 2012. 345(12): p. 964-972. PMID[23018557].

[PubMed]. HIV_1123-120612.

15. Synthesis, Biological Evaluation and Molecular Modeling of 4,6-Diarylpyrimidines and Diarylbenzenes as Novel Non-nucleosides HIV-1 Reverse Transcriptase Inhibitors. Ribone, S.R., V. Leen, M. Madrid, W. Dehaen, D. Daelemans, C. Pannecouque, and M.C. Brinon. European Journal of Medicinal Chemistry, 2012. 58: p. 485-492. PMID[23159806].

[PubMed]. HIV_1123-120612.

16. Synthesis, Evaluation and Structure-Activity Relationships of Triazine Dimers as Novel Antiviral Agents. Venkatraj, M., K.K. Arien, J. Heeres, J. Joossens, J. Messagie, J. Michiels, P. Van der Veken, G. Vanham, P.J. Lewi, and K. Augustyns. Bioorganic & Medicinal Chemistry Letters, 2012. 22(23): p. 7174-7178. PMID[23084903].

[PubMed]. HIV_1123-120612.

17. Synthesis, Evaluation of anti-HIV-1 and anti-HCV Activity of Novel 2',3'-Dideoxy-2',2'-difluoro-4'-azanucleosides. Martinez-Montero, S., S. Fernandez, Y.S. Sanghvi, E.A. Theodorakis, M.A. Detorio, T.R. McBrayer, T. Whitaker, R.F. Schinazi, V. Gotor, and M. Ferrero. Bioorganic & Medicinal Chemistry, 2012. 20(23): p. 6885-6893. PMID[23085031].

[PubMed]. HIV_1123-120612.

18. Synthesis, Structure-Activity Relationships, and Docking Studies of N-Phenylarylformamide Derivatives (PAFAS) as Non-nucleoside HIV Reverse Transcriptase Inhibitors. Ma, X.D., Q.Q. He, X. Zhang, S.Q. Yang, L.M. Yang, S.X. Gu, Y.T. Zheng, F.E. Chen, and H.F. Dai. European Journal of Medicinal Chemistry, 2012. 58: p. 504-512. PMID[23164656].

[PubMed]. HIV_1123-120612.

19. Two Retroviruses Packaged in One Cell Line Can Combined Inhibit the Replication of HIV-1 in TZM-Bl Cells. Liang, Z., Z. Guo, X. Wang, X. Kong, and C. Liu. Virologica Sinica, 2012.

[Epub ahead of print];PMID[23188559].

[PubMed]. HIV_1123-120612.

ISI Web of Knowledge Citations

20. 1-(2-Mercaptobenzenesulfonyl)-3-hydroxyguanidines - Novel Potent Antiproliferatives, Synthesis and in Vitro Biological Activity. Brozewicz, K. and J. Slawinski. European Journal of Medicinal Chemistry, 2012. 55: p. 384-394. ISI[000309494100039].

[WOS]. HIV_1123-120612.

21. Anti HIV-1 Agents 6. Synthesis and anti-HIV-1 Activity of Indolyl Glyoxamides. Wang, Y., N. Huang, X. Yu, L.M. Yang, X.Y. Zhi, Y.T. Zheng, and H. Xu. Medicinal Chemistry, 2012. 8(5): p. 831-833. ISI[000309650400008].

[WOS]. HIV_1123-120612.

22. Anti-HIV and Immune Modulating Activities of IND02. Biedma, M.E., B. Connell, S. Schmidt, H. Lortat-Jacob, C. Moog, and E. Prakash. Retrovirology, 2012. 9(Suppl 2): p. 60. ISI[000309472100293].

[WOS]. HIV_1123-120612.

23. Arylazolyl(azinyl)Thioacetanilides. Part 10: Design, Synthesis and Biological Evaluation of Novel Substituted Imidazopyridinylthioacetanilides as Potent HIV-1 Inhibitors. Li, X., P. Zhan, H. Liu, D.Y. Li, L. Wang, X.W. Chen, H.Q. Liu, C. Pannecouque, J. Balzarini, E. De Clercq, and X.Y. Liu. Bioorganic & Medicinal Chemistry, 2012. 20(18): p. 5527-5536. ISI[000308808700024].

[WOS]. HIV_1123-120612.

24. Assessing a Theoretical Risk of Dolutegravir-induced Developmental Immunotoxicity in Juvenile Rats. Rhodes, M., S. Laffan, C. Genell, J. Gower, C. Maier, T. Fukushima, G. Nichols, and A.E. Bassiri. Toxicological Sciences, 2012. 130(1): p. 70-81. ISI[000310163200007].

[WOS]. HIV_1123-120612.

25. Carbamoyl Pyridone HIV-1 Integrase Inhibitors. 1. Molecular Design and Establishment of an Advanced Two-metal Binding Pharmacophore. Kawasuji, T., B.A. Johns, H. Yoshida, T. Taishi, Y. Taoda, H. Murai, R. Kiyama, M. Fuji, T. Yoshinaga, T. Seki, M. Kobayashi, A. Sato, and T. Fujiwara. Journal of Medicinal Chemistry, 2012. 55(20): p. 8735-8744. ISI[000310120700014].

[WOS]. HIV_1123-120612.

26. Enhanced Recognition and Neutralization of HIV-1 by Antibody-derived CCR5-mimetic Peptide Variants. Chiang, J.J., M.R. Gardner, T. Dorfman, H. Choe, and M. Farzan. Journal of Virology, 2012. 86(22): p. 12417-12421. ISI[000310356400045].

[WOS]. HIV_1123-120612.

27. Human Intestinal Beta Defensins Inhibit Viral Replication and are Diminished in Chronic Untreated HIV Infection. Corleis, B., W.G. Gostic, J.A. Johnson, and D.S. Kwon. Retrovirology, 2012. 9(Suppl 2): p. 60. ISI[000309472100275].

[WOS]. HIV_1123-120612.

28. In vitro Evolution of an HIV Integrase Binding Protein from a Library of C-terminal Domain Gamma S-crystallin Variants. Moody, I.S., S.C. Verde, C.M. Overstreet, W.E. Robinson, and G.A. Weiss. Bioorganic & Medicinal Chemistry Letters, 2012. 22(17): p. 5584-5589. ISI[000308046400045].

[WOS]. HIV_1123-120612.

29. A Laccase with Antiproliferative and HIV-I Reverse Transcriptase Inhibitory Activities from the Mycorrhizal Fungus Agaricus placomyces. Sun, J., Q.J. Chen, Q.Q. Cao, Y.Y. Wu, L.J. Xu, M.J. Zhu, T.B. Ng, H.X. Wang, and G.Q. Zhang. Journal of Biomedicine and Biotechnology, 2012.

[Epub ahead of print]; ISI[000309777600001].

[WOS]. HIV_1123-120612.

30. The M-T Hook Structure Is Critical for Design of HIV-1 Fusion Inhibitors. Chong, H.H., X. Yao, J.P. Sun, Z.L. Qiu, M. Zhang, S. Waltersperger, M.T. Wang, S. Cui, and Y.X. He. Journal of Biological Chemistry, 2012. 287(41): p. 34558-34568. ISI[000309654200059].

[WOS]. HIV_1123-120612.

31. New Aryl-1,3-thiazole-4-carbohydrazides, Their 1,3,4-oxadiazole-2-thione, 1,2,4-triazole, Isatin-3-ylidene and Carboxamide Derivatives. Synthesis and anti-HIV Activity. Zia, M., T. Akhtar, S. Hameed, and N.A. Al-Masoudi. Zeitschrift Fur Naturforschung Section B, 2012. 67(7): p. 747-758. ISI[000309629500011].

[WOS]. HIV_1123-120612.

32. One Pot Efficient Diversity Oriented Synthesis of Polyfunctional Styryl Thiazolopyrimidines and Their Bio-evaluation as Antimalarial and anti-HIV Agents. Fatima, S., A. Sharma, R. Saxena, R. Tripathi, S.K. Shukla, S.K. Pandey, and R.P. Tripathi. European Journal of Medicinal Chemistry, 2012. 55: p. 195-204. ISI[000309494100021].

[WOS]. HIV_1123-120612.

33. Pharmacodynamic and Antiretroviral Activities of Combination Nanoformulated Antiretrovirals in HIV-1-Infected Human Peripheral Blood Lymphocyte-reconstituted Mice. Roy, U., J. McMillan, Y. Alnouti, N. Gautum, N. Smith, S. Balkundi, P. Dash, S. Gorantla, A. Martinez-Skinner, J. Meza, G. Kanmogne, S. Swindells, S.M. Cohen, R.L. Mosley, L. Poluektova, and H.E. Gendelman. Journal of Infectious Diseases, 2012. 206(10): p. 1577-1588. ISI[000310220000014].

[WOS]. HIV_1123-120612.

34. Purification and Characterization of anti-HIV-1 Protein from Canna indica L. Leaves. Thepouyporn, A., C. Yoosook, W. Chuakul, K. Thirapanmethee, C. Napaswad, and C. Wiwat. Southeast Asian Journal of Tropical Medicine and Public Health, 2012. 43(5): p. 1153-1160. ISI[000309639500010].

[WOS]. HIV_1123-120612.

35. Structure-activity Relationship Study of Pyrimido 1,2-C 1,3 benzothiazin-6-imine Derivatives for Potent anti-HIV Agents. Mizuhara, T., S. Oishi, H. Ohno, K. Shimura, M. Matsuoka, and N. Fujii. Bioorganic & Medicinal Chemistry, 2012. 20(21): p. 6434-6441. ISI[000310185900022].

[WOS]. HIV_1123-120612.

36. Structures and Biological Activity of Cinnamoyl Derivatives of Coumarins and Dehydroacetic acid and Their Boron difluoride Complexes. Tambov, K.V., I.V. Voevodina, A.V. Manaev, Y.A. Ivanenkov, N. Neamati, and V.F. Traven. Russian Chemical Bulletin, 2012. 61(1): p. 78-90. ISI[000310470000012].

[WOS]. HIV_1123-120612.

37. Synthesis and anti-HIV Activities of Symmetrical Dicarboxylate Esters of Dinucleoside Reverse Transcriptase Inhibitors. Agarwal, H.K., K.W. Buckheit, R.W. Buckheit, and K. Parang. Bioorganic & Medicinal Chemistry Letters, 2012. 22(17): p. 5451-5454. ISI[000308046400019].

[WOS]. HIV_1123-120612.

38. Synthesis and anti-HIV Evaluation of New 2-Thioxoimidazolidin-4-ones and Their Arylidine (styryl) Derivatives. Mahajan, D.H., K.H. Chikhalia, C. Pannecouque, and E. De Clercq. Pharmaceutical Chemistry Journal, 2012. 46(3): p. 165-170. ISI[000307980100005].

[WOS]. HIV_1123-120612.

39. Synthesis of 5-Methyl-1,3-oxathiolane-based Nucleoside Analogues as Potential Antiviral Agents. Franchini, S., A. Tait, C. Sorbi, and L. Brasili. Medicinal Chemistry, 2012. 8(5): p. 769-778. ISI[000309650400001].

[WOS]. HIV_1123-120612.

Patent Citations

40. Preparation of Phenylacetic Acid Derivatives as Inhibitors of Viral Replication. Chasset, S., F. Chevreuil, B. Ledoussal, F. Le Strat, and R. Benarous. Patent. 2012. 2012-EP56851 2012140243: 252pp.

[Patent]. HIV_1123-120612.

41. Designer Cyclic Peptides-HIV Gp120 Antagonists and Their Applications. Czyryca, P. Patent. 2012. 2012-452684 20120270806: 10pp.

[Patent]. HIV_1123-120612.

42. Method for Preparation of Baculiferin L and Its Analogue, Their Application for Treating AIDS. Fan, A., W. Lin, Y. Jia, and M. Xu. Patent. 2012. 2011-10077956 102718696: 15pp.

[Patent]. HIV_1123-120612.

43. Chromone Compound, Preparation Method, Application, anti-AIDS Medicinal Composition and Medicinal Preparation Thereof. Hu, Q., X. Gao, Y. Ye, Y. Shen, L. Su, and L. Yang. Patent. 2012. 2012-10291009 102775375: 12pp.

[Patent]. HIV_1123-120612.

44. Preparation of 4,4-Disubstituted-dihydro-2(1H)-quinazolinone or Thione-like Compounds as HIV Reverse Transcriptase Inhibitors for the Treatment of HIV. Jiang, B., C. Zhang, J. Li, S. Teng, X. Du, D. Zhuang, L. Zhang, H. Jiang, X. Cao, W. Wang, and H. Chen. Patent. 2012. 2011-10078047 102718721: 41pp.

[Patent]. HIV_1123-120612.

45. Modification of Nucleic Acids and Their Use as anti-HIV-1 Agents. Liu, K., J. He, L. Xu, W. Chen, L. Cai, B. Zheng, and K. Wang. Patent. 2012. 2012-CN75063 2012149906: 61pp.

[Patent]. HIV_1123-120612.

46. Preparation of Cyclopeptides for Treatment of HIV Infection. Liu, K., Q. Jia, X. Jiang, S. Liu, L. Li, M. Cheng, L. Cai, B. Zheng, and K. Wang. Patent. 2012. 2012-CN73988 2012139519: 21pp.

[Patent]. HIV_1123-120612.

47. Thioamide, Amidoxime and Amidrazone Derivatives as HIV Attachment Inhibitors. Meanwell, N.A., T. Wang, Z. Zhang, L.G. Hamann, and J.F. Kadow. Patent. 2012. 2012-US33007 2012142080: 82pp.

[Patent]. HIV_1123-120612.

48. Preparation of Benzothiazole Compounds as Antiviral Agents for the Treatment of HIV Infection. Mitchell, M.L., P.A. Roethle, L. Xu, H. Yang, R. McFadden, and K. Babaoglu. Patent. 2012. 2012-US34593 2012145728: 207pp.

[Patent]. HIV_1123-120612.

49. Synthetic Flavonoids and Pharmaceutical Compositions and Therapeutic Methods of Treatment of HIV Infection and Other Pathologies. Redda, K., C.J. Mills, and N. Maleeva. Patent. 2012. 2007-968146 20120264820: 23pp.

[Patent]. HIV_1123-120612.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2022